| Cash Flow | 2024-12-31 |
|---|---|
| Impairment expense | 336,758 |
| Loss on supplier deposits | 0 |
| Gain on divestiture of affiliate | 0 |
| Loss on debt extinguishment | -6,004 |
| Inducement expense | 7,714 |
| Equity in net loss of affiliates | -1,630 |
| Loss from continuing operations | -958,229 |
| Depreciation and amortization | 46,018 |
| Stock-based compensation | 31,969 |
| Revaluation of financial instruments | -10,096 |
| Revaluation of contingent stock consideration | 0 |
| Inventory write-downs | 87,977 |
| Non-cash interest expense | 19,500 |
| Net losses on asset sales and disposals | -10,374 |
| Other non-cash activity | 5,860 |
| Accounts receivable, net | 15,407 |
| Inventory | 99,404 |
| Prepaid expenses and other current assets | 5,469 |
| Long-term deposits | 163 |
| Other assets | 1,403 |
| Accounts payable, accrued expenses and other current liabilities | -28,900 |
| Operating lease liabilities | -3,623 |
| Other long-term liabilities | 27,194 |
| Net cash used in operating activities | -521,504 |
| Purchases and deposits for property, plant and equipment | 47,015 |
| Divestiture of affiliates | 0 |
| Proceeds from the sale of assets | 21,806 |
| Payments to assignee | 0 |
| Investments in affiliates | 0 |
| Net cash used in investing activities | -25,209 |
| Proceeds from issuance of common stock under equity distribution agreements, net of commissions and other fees paid | 144,088 |
| Proceeds from issuances of convertible debt instruments, net of discount and issuance costs | 80,000 |
| Proceeds from insurance premium financing | 5,786 |
| Proceeds from public offerings, net of underwriter's discount-Public Offering | 0 |
| Proceeds from issuance of shares-Private Placement | 0 |
| Proceeds from issuance of shares-Private Offering | 0 |
| Proceeds from the exercise of stock options | 0 |
| Proceeds from issuance of financing obligations, net of issuance costs | 0 |
| Repayment of senior convertible notes | 39,415 |
| Payments on finance lease liabilities and financing obligation | 5,553 |
| Payments on insurance premium financing | 5,100 |
| Payment for coupon make-whole premiums | 4,579 |
| Repayments of collateralized promissory notes | 787 |
| Other financing activities | -80 |
| Net cash provided by financing activities | 174,360 |
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | -372,353 |
| Cash and cash equivalents at beginning of period | 493,965 |
| Cash and cash equivalents at end of period | 121,612 |
Nikola Corp (NKLAQ)
Nikola Corp (NKLAQ)